[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1131552A1 - Soft chewable veterinary antibiotic formulations - Google Patents

Soft chewable veterinary antibiotic formulations

Info

Publication number
HK1131552A1
HK1131552A1 HK09110355.9A HK09110355A HK1131552A1 HK 1131552 A1 HK1131552 A1 HK 1131552A1 HK 09110355 A HK09110355 A HK 09110355A HK 1131552 A1 HK1131552 A1 HK 1131552A1
Authority
HK
Hong Kong
Prior art keywords
soft chewable
chewable veterinary
antibiotic formulations
veterinary antibiotic
formulations
Prior art date
Application number
HK09110355.9A
Other languages
English (en)
Inventor
Mark David Soll
Albert Boeckh
Monica Tejwani-Motwani
Robert P Waranis
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of HK1131552A1 publication Critical patent/HK1131552A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK09110355.9A 2006-09-07 2009-11-06 Soft chewable veterinary antibiotic formulations HK1131552A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84287706P 2006-09-07 2006-09-07
PCT/US2007/019357 WO2008030469A2 (en) 2006-09-07 2007-09-05 Soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations

Publications (1)

Publication Number Publication Date
HK1131552A1 true HK1131552A1 (en) 2010-01-29

Family

ID=38881630

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09110355.9A HK1131552A1 (en) 2006-09-07 2009-11-06 Soft chewable veterinary antibiotic formulations

Country Status (8)

Country Link
US (1) US20080160067A1 (xx)
EP (1) EP2063869B1 (xx)
AU (1) AU2007293068C1 (xx)
CA (1) CA2662827C (xx)
HK (1) HK1131552A1 (xx)
MX (1) MX2009002552A (xx)
NZ (1) NZ575435A (xx)
WO (1) WO2008030469A2 (xx)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2510196C (en) * 2002-12-20 2014-04-01 Generipharm, Inc. Intracutaneous injection
EP2200613B1 (en) 2007-09-21 2018-09-05 The Johns Hopkins University Phenazine derivatives and uses thereof
EP2313083A1 (en) * 2008-07-22 2011-04-27 Lupin Limited Oral compositions of clindamycin
US20100028677A1 (en) * 2008-07-31 2010-02-04 University Of North Carolina At Greensboro Nano-metallic alloy delivery system for treatment of infected cells and legions
EP2332916A3 (en) 2009-11-19 2011-08-03 Krka Tovarna Zdravil, D.D., Novo Mesto A process for a preparation of marbofloxacin and intermediate thereof
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
CA2814082A1 (en) * 2010-10-12 2012-04-19 Bayer Intellectual Property Gmbh Non-starch based soft chewables
ES2621304T3 (es) 2011-03-10 2017-07-03 Xeris Pharmaceuticals, Inc. Formulaciones estables para inyección parenteral de fármacos peptídicos
MX352760B (es) 2011-09-09 2017-12-07 Merck Sharp & Dohme Corp Star Metodos para tratar infecciones intrapulmonares.
JP6290081B2 (ja) * 2011-09-15 2018-03-07 フリウルケム、ソシエタ、ペル、アチオニFriulchem Spa 動物への経口投与用組成物、その製造方法およびその使用
ES2574761T3 (es) 2011-10-31 2016-06-21 Xeris Pharmaceuticals, Inc. Formulaciones para el tratamiento de la diabetes
PT109395B (pt) 2012-02-06 2020-10-01 Boehringer Ingelheim Animal Health USA Inc. Composições veterinárias orais parasiticidas compreendendo agentes activos de actuação sistémica, métodos e as suas utilizações
BR112014024833B1 (pt) 2012-04-04 2022-10-04 Intervet International B.V. Produto farmacêutico veterinário mastigável macio, processo para sua fabricação e seu uso, bem como uso de pamoato de sódio
US9661830B2 (en) 2012-04-17 2017-05-30 Big Heart Pet, Inc. Appetizing and dentally efficacious animal chews
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
US8809314B1 (en) 2012-09-07 2014-08-19 Cubist Pharmacueticals, Inc. Cephalosporin compound
US8476425B1 (en) 2012-09-27 2013-07-02 Cubist Pharmaceuticals, Inc. Tazobactam arginine compositions
MX347401B (es) * 2012-11-14 2017-04-18 Univ Mexico Nac Autonoma Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
CN103142990B (zh) * 2013-03-14 2015-01-28 山东信得科技股份有限公司 一种治疗畜禽细菌性疾病的药物及其制备方法
CA2906295C (en) 2013-03-15 2019-01-22 Argenta Manufacturing Limited Chewable formulation
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
NZ700372A (en) 2013-03-15 2016-01-29 Merck Sharp & Dohme Ceftolozane antibiotic compositions
US20140274991A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
US20140377355A1 (en) * 2013-06-19 2014-12-25 Professional Compounding Centers Of America Levofloxacin Inhalation Composition
US20140377357A1 (en) * 2013-06-19 2014-12-25 Professional Compounding Centers Of America Poloxamer Based Inhalation Composition
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
MX364800B (es) * 2014-02-18 2019-04-26 Univ Mexico Nac Autonoma Tilmicosina de accion prolongada mejorada y el uso de la misma en el tratamiento del complejo respiratorio bovino (crb) y en el periodo de la vaca seca.
US9763934B2 (en) * 2014-03-05 2017-09-19 Professional Compounding Centers Of America Synergistic effect of poloxamer-based composition and itraconazole on fungus and yeast
WO2015134822A1 (en) * 2014-03-05 2015-09-11 Professional Compounding Centers Of America Poloxamer-based pharmaceutical compositions for treating wounds
CN106573106B (zh) 2014-08-06 2021-06-22 Xeris药物公司 用于皮内和/或皮下注射糊剂的注射器、试剂盒和方法
CN104365581B (zh) * 2014-11-05 2016-08-24 中山大学 一种新型标本保存液
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
CA2988575C (en) 2015-06-10 2024-04-16 Piedmont Animal Health, Llc Injectable antibiotic formulations and use thereof
RU2600924C1 (ru) * 2015-06-19 2016-10-27 Общество с ограниченной ответственностью "Научно-исследовательский центр "Полимерные соединения" Способ получения фармацевтической композиции эритромицина
US9808010B2 (en) 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
CN105213304A (zh) * 2015-10-22 2016-01-06 四川恒通动物制药有限公司 一种头孢氨苄混悬注射液及其制备方法
CN105310979A (zh) * 2015-10-30 2016-02-10 江苏大红鹰恒顺药业有限公司 克林霉素磷酸酯注射液及其制备方法
CN105853389A (zh) * 2016-04-28 2016-08-17 湖南尔康湘药制药有限公司 磺胺嘧啶淀粉胶囊及其制备方法
EP3630061B1 (en) 2017-06-02 2024-04-03 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations
CN110996920A (zh) 2017-07-26 2020-04-10 太杰先软嚼有限责任公司 用于兽医应用的无淀粉软咀嚼物
BR112020003235A2 (pt) * 2017-08-17 2020-08-18 Ceva Sante Animale composições orais e métodos de preparação das mesmas
CN109512791A (zh) * 2019-01-09 2019-03-26 佛山市南海东方澳龙制药有限公司 一种宠物用头孢羟氨苄咀嚼片及其制备方法
UA126843C2 (uk) * 2019-02-20 2023-02-08 Зоетіс Сервісіс Ллк Лікарські форми з приємним смаком
WO2020234898A1 (en) * 2019-05-21 2020-11-26 Cuckos Pharmaceutical Private Limited Process for manufacturing soft chewable free flowing granules and companion animal products thereof
CN110179756A (zh) * 2019-06-20 2019-08-30 河北利华药业有限公司 一种替米考星制剂及其制备方法
CN110559264A (zh) * 2019-09-24 2019-12-13 李会芳 一种用于制作头孢喹肟药敏片的组合物
CN110898022A (zh) * 2019-12-31 2020-03-24 湖南嘉恒制药有限公司 一种异烟肼组合物及其制备方法
CN113209015A (zh) * 2020-01-21 2021-08-06 江西邦诚动物药业有限公司 长效盐酸头孢噻呋混悬注射液及其制备工艺
CN114748495B (zh) * 2022-05-18 2023-02-03 广东温氏大华农生物科技有限公司 一种油水双溶的兽用林可大观复方制剂及其制备方法和应用
CN115813868B (zh) * 2022-12-06 2024-06-28 江西省保灵动物保健品有限公司 一种高溶出头孢泊肟酯片剂及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245352B1 (en) * 1999-04-27 2001-06-12 Eli Lilly And Company Pharmaceutical formulation
US20030129236A1 (en) * 2001-12-20 2003-07-10 Heimlich John M. Multiple pulse extended release formulations of clindamycin
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations

Also Published As

Publication number Publication date
EP2063869A2 (en) 2009-06-03
WO2008030469A2 (en) 2008-03-13
AU2007293068B2 (en) 2013-05-23
MX2009002552A (es) 2009-03-30
NZ575435A (en) 2012-01-12
CA2662827C (en) 2015-04-07
WO2008030469A3 (en) 2008-07-24
AU2007293068C1 (en) 2013-09-19
EP2063869B1 (en) 2014-03-05
AU2007293068A1 (en) 2008-03-13
US20080160067A1 (en) 2008-07-03
CA2662827A1 (en) 2008-03-13

Similar Documents

Publication Publication Date Title
HK1131552A1 (en) Soft chewable veterinary antibiotic formulations
GB2455032B (en) Offset matrix adapter for toy construction sets
GB2435419B (en) Formulations
EP2046930A4 (en) FORMULATIONS BASED ON RHAMNOLIPIDS
GB0605780D0 (en) Formulations
HK1180949A1 (en) Long lasting drug formulations
GB0718409D0 (en) Formulations
EP1980237A4 (en) GELIFYING AGENT
IL196883A0 (en) Antibiotic composition
GB0610336D0 (en) Formulations
GB0622582D0 (en) Animal feeds and veterinary compositions
GB0615108D0 (en) Novel formulations
GB0624565D0 (en) Veterinary composition
AP2007004083A0 (en) Anthelmintic composition
ZA200810676B (en) Novel aminoglycoside antibiotics
IL198760A0 (en) Oral formulations
IL198160A0 (en) Pharmaceutical formulations
GB0621181D0 (en) Vaginal speculum
GB0718404D0 (en) Formulations
GB0508991D0 (en) Veterinary composition
SI1911455T1 (sl) Farmacevtski sestavki za topično vaginalno aplikacijo
ZA200807682B (en) Novel formulations
GB2447747B (en) Antibacterial formulations
GB0603380D0 (en) Formulations
GB0611519D0 (en) Formulations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190911